Correlation Between Tempest Therapeutics and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and ProQR Therapeutics BV, you can compare the effects of market volatilities on Tempest Therapeutics and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and ProQR Therapeutics.
Diversification Opportunities for Tempest Therapeutics and ProQR Therapeutics
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tempest and ProQR is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and ProQR Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 6.96 times more return on investment than ProQR Therapeutics. However, Tempest Therapeutics is 6.96 times more volatile than ProQR Therapeutics BV. It trades about 0.04 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about 0.05 per unit of risk. If you would invest 130.00 in Tempest Therapeutics on August 28, 2024 and sell it today you would lose (38.00) from holding Tempest Therapeutics or give up 29.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Tempest Therapeutics vs. ProQR Therapeutics BV
Performance |
Timeline |
Tempest Therapeutics |
ProQR Therapeutics |
Tempest Therapeutics and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tempest Therapeutics and ProQR Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |